- Home
- DNTH vs IRT Comparison
DNTH vs IRT Comparison
Compare DNTH & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | IRT |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.1B |
| IPO Year | 2018 | 2009 |
Fundamental Metrics
Financial Performance| Metric | DNTH | IRT |
|---|---|---|
| Price | $88.63 | $16.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $121.00 | $20.45 |
| AVG Volume (30 Days) | 523.2K | ★ 2.0M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | N/A | ★ 41.18 |
| EPS | N/A | ★ N/A |
| Revenue | $2,036,000.00 | ★ $657,696,000.00 |
| Revenue This Year | N/A | $3.21 |
| Revenue Next Year | $29.48 | $3.54 |
| P/E Ratio | ★ N/A | $68.10 |
| Revenue Growth | N/A | ★ 2.76 |
| 52 Week Low | $16.77 | $14.60 |
| 52 Week High | $96.50 | $19.61 |
Technical Indicators
Market Signals| Indicator | DNTH | IRT |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 64.70 |
| Support Level | $33.94 | $15.97 |
| Resistance Level | $96.50 | $16.49 |
| Average True Range (ATR) | 4.02 | 0.36 |
| MACD | -1.21 | 0.09 |
| Stochastic Oscillator | 45.82 | 96.71 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.